Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Shamia Hoque"'
Autor:
Charles L. Bennett, Nancy Olivieri, Shamia Hoque, David Aboulafia, Anne Ventrone, Courtney Lubaczewski, Betty Dong, Benjamin Schooley, Bartlett J. Witherspoon, Paul S. Ray, William J. Hrushesky, John Restaino, Henrik S. Thomsen, Dennis Mangano, Christina Mora-Mangano, June M. McKoy, Martin Schoen, Kevin Knopf, Linda Martin, Steven Rosen
Publikováno v:
The Journal of Scientific Practice and Integrity (2022)
# Background We previously described experiences of clinicians who published adverse drug reaction reports. We now report on threats and intimidations leveled against clinicians and scientists who received publicly documented threats after communica
Externí odkaz:
https://doaj.org/article/c58a1f473a3e44cfa3fb8a9e0941656a
Autor:
Charles L. Bennett, Shamia Hoque, Nancy Olivieri, Matthew A. Taylor, David Aboulafia, Courtney Lubaczewski, Andrew C. Bennett, Jay Vemula, Benjamin Schooley, Bartlett J. Witherspoon, Ashley C Godwin, Paul S. Ray, Paul R. Yarnold, Henry C. Ausdenmoore, Marc Fishman, Georgne Herring, Anne Ventrone, Juan Aldaco, William J. Hrushesky, John Restaino, Henrik S. Thomsen, Robert Marx, Cesar Migliorati, Salvatore Ruggiero, Chadi Nabhan, Kenneth R. Carson, June M. McKoy, Y. Tony Yang, Martin W. Schoen, Kevin Knopf, Linda Martin, Oliver Sartor, Steven Rosen, William K. Smith
Publikováno v:
EClinicalMedicine, Vol 31, Iss , Pp 100693- (2021)
Background: Adverse drug/device reactions (ADRs) can result in severe patient harm. We define very serious ADRs as being associated with severe toxicity, as measured on the Common Toxicity Criteria Adverse Events (CTCAE)) scale, following use of drug
Externí odkaz:
https://doaj.org/article/7660e72814e34fe8aaa2b0680f081e61
Autor:
Shamia Hoque, Brian J Chen, Martin W Schoen, Kenneth R Carson, Jesse Keller, Bartlett J Witherspoon, Kevin B Knopf, Y Tony Yang, Benjamin Schooley, Chadi Nabhan, Oliver Sartor, Paul R Yarnold, Paul Ray, Laura Bobolts, William J Hrushesky, Michael Dickson, Charles L Bennett
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234541 (2020)
Erythropoisis stimulating agent (ESA) use was addressed in Food and Drug Administration (FDA) Oncology Drug Advisory Committee (ODAC) meetings between 2004 and 2008. FDA safety-focused regulatory actions occurred in 2007 and 2008. In 2007, black box
Externí odkaz:
https://doaj.org/article/db22cc567bfb42b08476116e945c2620
Publikováno v:
Cancer treatment and research. 184
About 1-10% of all serious adverse drug reactions (sADRs) are reported to the Food and Drug Administration (FDA) ( Moore T, Bennett C. Underreporting of Hemorrhagic and Thrombotic Complications of Pharmaceuticals to the U.S. Food and Drug Administrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7f814c73f97c53675713d6cf85ea5c84
https://pubmed.ncbi.nlm.nih.gov/36449189
https://pubmed.ncbi.nlm.nih.gov/36449189
Autor:
Shannon, Ugarte, Paul, Yarnold, Paul, Ray, Kevin, Knopf, Shamia, Hoque, Matthew, Taylor, Charles L, Bennett
Publikováno v:
Cancer treatment and research. 184
Logistic regression is a statistical tool of paramount significance in the field of epidemiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e75f7869ab4275a071305d87d4afe90
https://pubmed.ncbi.nlm.nih.gov/36449192
https://pubmed.ncbi.nlm.nih.gov/36449192
Publikováno v:
Journal of Cancer Research & Therapy. 9:1-11
Throughout the last decade, utilization of machine learning has seen a sharp rise in fields such as computing, transportation, engineering, and medicine. Artificial neural networks (ANNs) have demonstrated increased application due to their versatili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c77e32004df02852637d044a55f9d63b
https://doi.org/10.14312/2052-4994.2021-1
https://doi.org/10.14312/2052-4994.2021-1
Autor:
David M. Aboulafia, Bartlett J. Witherspoon, Shamia Hoque, Michael D. Wyatt, Y. Tony Yang, Paul R. Yarnold, William J. M. Hrushesky, Catherine S Hwang, Brian Chen, Paul Ray, Martin W. Schoen, Charles L. Bennett, Matthew A. Taylor, Benjamin Schooley
Publikováno v:
The Lancet Oncology. 21:e575-e588
The EU, the USA, and Japan account for the majority of biological pharmacotherapy use worldwide. Biosimilar regulatory approval pathways were authorised in the EU (2006), in Japan (2009), and in the USA (2015), to facilitate approval of biological dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a461ff1bb3e423585411bbf71cf37665
https://doi.org/10.1016/s1470-2045(20)30485-x
https://doi.org/10.1016/s1470-2045(20)30485-x
Autor:
Shamia Hoque, Michael Dickson, Paul R. Yarnold, Oliver Sartor, Bartlett J. Witherspoon, Benjamin Schooley, Chadi Nabhan, Charles L. Bennett, Brian J. Chen, William J. M. Hrushesky, Y. Tony Yang, Martin W. Schoen, Kevin B. Knopf
Publikováno v:
International Journal of Cancer. 146:2829-2835
Erythropoiesis-stimulating agents (ESAs) are available to treat chemotherapy-induced anemia (CIA). In 2007-2008, regulatory notifications advised of venous thromboembolism and mortality risks while the Center for Medicare and Medicaid Services' restr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b16c80598f233cab573dcabed1e7160
https://doi.org/10.1002/ijc.32917
https://doi.org/10.1002/ijc.32917
Autor:
Charles L. Bennett, Shamia Hoque
Publikováno v:
Cancer Drug Safety and Public Health Policy ISBN: 9783031044014
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae4b63c13885e8ef30c04ce84f22c329
https://doi.org/10.1007/978-3-031-04402-1_9
https://doi.org/10.1007/978-3-031-04402-1_9
